About James La Rossa

This author has not yet filled in any details.
So far James La Rossa has created 179 blog entries.

Psychopharmacology Bulletin Pens Ventures with EbscoHost, Elsevier, and Bio-Press; 2016 Issues, Set for Index Medicus, are In Press

By |2016-03-05T22:18:10-08:00March 5th, 2016|We Know Psychiatry|

For Immediate Release March 7, 2016. Los Angeles CA Contact: James La Rossa Jr., 310.374.1300 2016 Issues, Set for Index Medicus, are In Press Psychopharmacology Bulletin — reactivated by the National Library of Medicine — has finalized a series of agreements with the largest repositories of acquisitions medical libraries. Bulletin [...]

Medical Advertising in the Crosshairs

By |2016-02-29T16:31:12-08:00February 29th, 2016|We Know Psychiatry|

In the summer of 1997, I was months away from launching the first consumer magazine about mental illness. My company had acquired a state and federal trademark for the title, Mental Fitness (The Science of Mental Wellness). I had done a long interview with the veteran 60 Minutes journalist, Mike [...]

Commonly Used P.P.I.s Tied to Brain Disease

By |2016-02-23T20:20:29-08:00February 23rd, 2016|We Know Psychiatry|

Proton Pump Inhibitor's (or P.P.I.s), widely available by prescription or over the counter brands like Prevacid, Nexium, and Prilosec, have been tied to Alzheimer's Disease and other dementias, according to German researchers writing in JAMA Neurology. The researchers looked for five years at 73,679 men and women over 75 who were [...]

Preventing Weight Gain in Women in Rural Communities: A Cluster Randomised Controlled Trial

By |2016-02-02T02:25:23-08:00February 2nd, 2016|We Know Psychiatry|

By Catherine Lombard, Cheryce Harrison, Samantha Kozica, Sophia Zoungas, Sanjeeva Ranasinha, and Helena Teede   Abstract Background Obesity is reaching epidemic proportions in both developed and developing countries. Even modest weight gain increases the risk for chronic illness, yet evidence-based interventions to prevent weight gain are rare. This trial will determine if a simple low-intensity intervention [...]

A Drug to Cure Fear

By |2016-01-25T13:57:21-08:00January 25th, 2016|We Know Psychiatry|

According to Richard A. Friedman, a professor of clinical psychiatry and the director of the psychopharmacology clinic at the Weill Cornell Medical College, writing in Sunday's New York Times, "Who among us hasn’t wanted to let go of anxiety or forget about fear?" Phobias, panic attacks and disorders like post-traumatic stress are extremely [...]

Famed Cardiologist Robert Califf Thwarted by Senate Salmon to Head FDA

By |2016-01-13T16:17:51-08:00January 13th, 2016|We Know Psychiatry|

In a clear signal that medicine and politics make strange bedfellows, a crucial Senate committee on Tuesday, which unanimously approved Dr. Robert M. Califf, a cardiologist and clinical trial expert from Duke University as the commissioner of the Food and Drug Administration, is unlikely to happen soon, because Senator Lisa Murkowski [...]

Psychiatric Publisher Goes Digital

By |2015-12-31T17:17:29-08:00December 31st, 2015|We Know Psychiatry|

For Immediate Release December 31, 2015. Los Angeles CA Contact: James La Rossa Jr., 310.374.1300 MedWorks Media Inc., established in 1994 as one of the largest publishers of journals and educational medical projects about psychiatric medicine, was reconfigured for a 2016 launch as a cutting-edge digital portal and publisher — [...]

Go to Top